November 2024 • PharmaTimes Magazine • 4-5


Contents


Features

Pharma is waking up to its environmental responsibilities


Humour and pharma – the power of an unlikely combo


Multiple uses for new brands are changing pharma’s data needs


Data collection methods reshaping drug research during pregnancy


Dr Amy Walker shares her experiences of the synthetic DNA revolution


Analysis

A framework to optimise R&D success alongside AI


Approval of lecanemab –
a pharmacovigilance perspective

We’re all getting older but what can we do to halt ageing's wicked ways?


How AI-enabled glucose prediction will change diabetes management


Unlocking brave new opportunities with advanced analytics


SmartPeople

16.
Trial transformers
Building partnerships with sites for more effective clinical trials


24.
A rare opportunity
Importance of continuous collaboration with rare disease communities


36.
Got the moves
People are glowing, showing and bestowing. Here's where they're going